Amazon Launches GLP-1 Weight Loss Program with One Medical
Amazon is now in the medical weight loss business.
Amazon One Medical has launched a comprehensive GLP-1 Management Program, integrating primary care, pharmacy services through Amazon Pharmacy, and virtual care options to help patients achieve lasting weight loss results.
According to the release, the program intends to proactively manage how weight loss intersects with cardiovascular health, metabolic conditions, and overall health. The patient journey includes pre-visit screening, structured consultations, and regular follow-up visits alongside integrated monitoring, standardized documentation, and evidence-based treatment algorithms with built-in safety protocols.
The available GLP-1s? Amazon Pharmacy offers the FDA-approved Wegovy (semaglutide, from Novo Nordisk) and Foundayo (orforglipron, from Eli Lilly) oral GLP-1 pills for weight management. Injectable versions on offer include prefilled Wegovy injectables, plus the Zepbound (tirzepatide, from Eli Lilly) auto-injector and multi-dose KwikPen.
Costs for the oral GLP-1 pills are expected to start as low as $25 per month with insurance, or cash pay starting at $149 per month. Injectable GLP-1s have cash-pay pricing starting at $299 per month. Customers can compare insurance and cash-pay prices side-by-side at checkout, with certain manufacturer coupons automatically applied to eligible customers at checkout.
Patients enrolled in the GLP-1 Management Program receive prescription renewals through their primary care clinician. For individuals who aren’t Amazon One Medical primary care patients, they can access on-demand, 24/7 telehealth prescription renewals, starting at $29 for message consultations or $49 for video care. This additional option is for individuals who already have a GLP-1 prescription and need quick prescription renewals while maintaining the existing medical supervision essential for long-term success. It is not for individuals seeking new prescriptions.
On Medical Weight Loss and Wellness
Med spas have seen the medical weight loss market explode in the last five years. Consumer demand for Wegovy and Ozempic (semaglutide, from Novo Nordisk) created an FDA-official shortage, which temporarily allowed prescribers to work with compounding pharmacies and build weight management programs into their practices at a lower cost to consumers. Telehealth e-prescribing brands including Ro, Hims and Hers, and Henry Meds quickly jumped in, offering easy, virtual access to personalized weight loss solutions.
When the shortage of these brand-name medications resolved, compounding GLP-1s was no longer allowed. Telehealth providers pivoted to more individualized offerings, still working with compounding pharmacies to make substantially different versions of these meds tailored to a patient’s specific needs, by adding ingredients or offering it in a not-yet-available oral form. The manufacturers quickly discouraged and filed lawsuits against companies that marketed unofficial products using the names or FDA approval of the original medications.
The brand-name medications have become widely available for consumers, with new consumer cash-pay programs and manufacturer-sanctioned prescribing platforms. You can find weight loss programs at Weight Watchers, Costco, GoodRx Care Direct, Noom, Hims and Hers, and many others.
Ozempic Face and Biostimulators
Medical weight loss has issed in a new demographic of aesthetic patient: those suffering from “Ozempic face.” The rapid weight loss from these GLP-1 medications can speed up facial volume loss and skin laxity, so patients who achieve their weight loss goals may feel less like themselves when they look in the mirror.
Leaders in aesthetic medicine such as Dr. Kay Durairaj, MD, FACS, of Beauty by Dr. Kay, have been investigating ways to prevent and treat this issue. Injectors are using a combination of hyaluronic acid (HA) dermal fillers and biostimulators to restore facial volume after medication derived weight loss. She’s also currently studying how collagen biostimulator treatments within three weeks of starting the first dose of GLP-1s can help patients get weight loss without the face loss. Her precise placement supports collagen stimulation, structural support, and rejuvenation with natural-looking results.
Dr. Kay recently curated comprehensive regenerative medicine education at AmSpa’s Medical Spa Show 2026, where she was joined by Dr. Robert Lufkin, Dr. Tess Mauricio, Dr. Mark Tager, Dr. Greg Chernoff, Alina Su, Kelly Nemiro, and Dr. Steven Sorr. Revisit their insights from the comfort of home through MSS Replay.